Provided by Tiger Fintech (Singapore) Pte. Ltd.

INNOCARE

14.480
+0.1200.84%
Volume:30.52M
Turnover:442.34M
Market Cap:25.50B
PE:-50.94
High:15.100
Open:14.460
Low:14.000
Close:14.360
Loading ...

Company Profile

Company Name:
INNOCARE
Exchange:
SEHK
Establishment Date:
2015
Employees:
1089
Office Location:
Building 8,No. 8 Life Science Park Road,Zhongguancun Life Science Park,Changping District,Beijing,China
Zip Code:
102206
Fax:
86 10 6070 2992
Introduction:
InnoCare Pharma Ltd is a China-based company mainly engaged in the research and development, production and commercialization of biopharmaceuticals. The Company focuses on areas with large unmet clinical needs, such as oncology and autoimmune diseases. The Company's primary product pipeline includes Orelabrutinib, Tafasitamab, ICP-490, ICP-B02, ICP-248, ICP-B05, ICP-332, ICP-488, ICP-192, ICP-723, ICP-033 and ICP-189, and others. Its products are mainly used to treat hematological tumors, solid tumors and autoimmune diseases. The Company is also developing products for the treatment of autoimmune diseases caused by abnormal B cell or T cell function. The Company mainly conducts its businesses in domestic and overseas markets.

Directors

Name
Position
Jisong Cui
Chairman of the Board,Executive Director,Core Technical Personnel,Member of the Remuneration and Assessment Committee,Chairman of the Nomination Committee,Member of the Nomination Committee
Zhao Renbin
Executive Director,Core Technical Personnel
HU Lan
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member,Audit Committee Chairman
DONG Dan Dan
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member
Kunliang Guan
Independent Director
SHI Yi Gong
Director
XIE Rong Gang
Director,Audit Committee Member
LI Xie Pei Shan
Corporate Secretary
Xiangyang Chen
Core Technical Personnel

Shareholders

Name
Position
Jisong Cui
CEO
FU Xin
CFO
Xiangyang Chen
CTO
YUAN Bei
Board Secretary